SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Scott will join a panel discussion focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
News | 05. 14. 2012
Scott will sit on a panel focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
